Cagent Vascular Announces PRELUDE-BTK Study Results
WAYNE, PA — Cagent Vascular, a developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its PRELUDE-BTK Study at this year’s LINC Symposium on January …
Read More